GlycA, a novel pro-inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta-analysis.
Eke G GruppenSetor Kwadzo KunutsorL M KienekerB van der VegtM A ConnellyG H de BockR T GansevoortS J L BakkerR P F DullaartPublished in: Journal of internal medicine (2019)
GlycA is significantly associated with all-cause mortality. GlycA and hsCRP were each not independently associated with cardiovascular mortality. The association of GlycA and hsCRP with cancer mortality appears to be driven by men.